Cargando…
De novo CACAN1D Ca(2+) channelopathies: clinical phenotypes and molecular mechanism
The identification of rare disease-causing variants in humans by large-scale next-generation sequencing (NGS) studies has also provided us with new insights into the pathophysiological role of de novo missense variants in the CACNA1D gene that encodes the pore-forming α1-subunit of voltage-gated Cav...
Autores principales: | Ortner, Nadine J., Kaserer, Teresa, Copeland, J. Nathan, Striessnig, Jörg |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7351864/ https://www.ncbi.nlm.nih.gov/pubmed/32583268 http://dx.doi.org/10.1007/s00424-020-02418-w |
Ejemplares similares
-
Germline de novo variant F747S extends the phenotypic spectrum of CACNA1D Ca(2+) channelopathies
por: Török, Ferenc, et al.
Publicado: (2022) -
Skeletal muscle Ca(V)1.1 channelopathies
por: Flucher, Bernhard E.
Publicado: (2020) -
Channelopathies in Ca(v)1.1, Ca(v)1.3, and Ca(v)1.4 voltage-gated L-type Ca(2+) channels
por: Striessnig, Jörg, et al.
Publicado: (2010) -
C-Terminal Modulatory Domain Controls Coupling of Voltage-Sensing to Pore Opening in Ca(v)1.3 L-type Ca(2+) Channels
por: Lieb, Andreas, et al.
Publicado: (2014) -
Neuronal Cav3 channelopathies: recent progress and perspectives
por: Lory, Philippe, et al.
Publicado: (2020)